Controversy Continues Over Power Morcellation

Tissue morcellation is by no means a new concept in laparoscopic surgery, but recent concerns regarding open power morcellation in gynecologic procedures have called the practice into question. What Are Power Morcellators? Gynecologists use power morcellators when they perform laproscopic procedures, such... Read More »

0

Blood Thinner Xarelto Implicated in New Lawsuit over Internal Bleeding

  Louisiana plaintiff William H. is suing two major pharmaceutical companies, Bayer and Janssen Pharmaceuticals, for the injuries he allegedly suffered from their drug Xarelto. William claims that as a direct result of ingesting the blood-thinner Xarelto, he developed severe and almost fatal... Read More »

0

Lipitor Guidelines Still Controversial

As with many areas of medicine, drugs like Lipitor carry both risks and benefits. While Lipitor can lower blood cholesterol levels, it may also increase the risk of type-2 diabetes. As doctors struggle to create guidelines to balance risk and reward, the... Read More »

0

AbbVie Faces AndroGel Testosterone Product Lawsuit

A married couple from Washington State has filed a testosterone product lawsuit against AbbVie, the makers of AndroGel. Their testosterone gel lawsuit joins others in alleging that testosterone products are dangerous and can cause blood clot related problems. Plaintiffs Wayne and Judy... Read More »

0

Citizen Petition: Add Psychiatric Risks to Quinolone Labels

Among the most widely used antibiotics in the United States are fluoroquinolones, which include Levaquin, Cipro, Avelox, Noroxin, Floxin and Factive. This class of drugs has been linked to variety of issues, including risks of peripheral neuropathy, tendon ruptures, and liver and... Read More »

0

Pfizer to Pay $3.78M in Dilantin SJS Settlement

In late October, Pfizer Inc. agreed to a $3.78 million Dilantin Toxic Epidermal Necrolysis (TEN) settlement to resolve a wrongful death Dilantin lawsuit brought forth by the family of a 9-year-old girl who allegedly died from TEN (an advanced stage of Stevens... Read More »

0

Medical Reports Warn Against Cymbalta Birth Defects

According to recent medical reports, the antidepressant drug Cymbalta has been linked with a high risk of in utero birth defects when taken by pregnant women. These birth defects can result in early miscarriage, but are more likely to cause life-threatening complications... Read More »

0

Risperdal Lawsuits Await Key Meeting With Judge

The law firm involved in the bulk of the Risperdal lawsuits is gearing up for a critical meeting in the consolidated legal action. A critical status conference is set for Dec. 2 for the Risperdal multidistrict litigation (MDL). At this meeting, representatives... Read More »

0

FDA Adds Stevens Johnson Warning to Onfi (Clobazam)

In late 2013, the U.S. Food and Drug Administration approved label changes to the seizure drug Onfi to warn patients about the risk of Stevens Johnson Syndrome. Onfi is the trade name of a seizure drug called clobazam. The drug has been in... Read More »

0

Women Over 60 Most at Risk of Developing Levaquin SJS

According to recent research and customer reviews, the fluoroquinolone drug Levaquin has been known to allegedly cause a painful and serious allergic skin reaction known as Stevens Johnson Syndrome (or SJS). Levaquin is part of the fluoroquinolone antibiotic drug family and is... Read More »

0

Melanoma Skin Cancer Associated With Erectile Dysfunction Drugs

More than 76,000 total new melanoma skin cancer cases, and nearly 10,000 deaths from melanoma cancer, are projected to occur in the United States during 2014, according to the Federal Government. While the most common cause of melanoma is too much exposure the... Read More »

0

Asthma Drug Xolair Gets FDA ‘Black Box’ Warning

Following a recent review of data from a five-year study conducted by Genentech, the U.S. Food and Drug Administration (FDA) determined in September that new Xolair warnings are needed about the potential risk of heart problems, brain problems and possibly even a... Read More »

0